Taken together, here we report that BMSCs from SLE patients had decreased migration capacity, which was related to elevated TNF-α serum level and was acted via a specific TNFRI manner to activate IKK-β and consequently inhibit HGF mRNA production. Here, TNF is linked to systemic lupus erythematosus.